MIRAPEX for RLS
Treating Restless Legs Syndrome with MIRAPEX.
MIRAPEX is a prescription medicine approved for the treatment of moderate to severe primary Restless Legs Syndrome (RLS). The active ingredient in MIRAPEX is called a nonergot dopamine agonist. Restless legs syndrome is a medical condition that is described as an urge to move the legs. This desire to move is often coupled with unpleasant sensations occurring in the legs that are relieved by movement.
MIRAPEX has been shown to relieve the frequency and severity of the symptoms of primary RLS, including the urge to move one's legs. It provides effective long-term relief.
It works quickly and safely.
MIRAPEX works by acting like dopamine to stimulate the nerve cells that control movement. MIRAPEX is rapidly absorbed, reaching peak concentrations in approximately 2 hours. And MIRAPEX has a well-established safety profile and has been shown to be well tolerated in patients with RLS who may have other common diseases.
If you or someone you know suffers from the symptoms of RLS, ask your doctor about MIRAPEX.
IMPORTANT SAFETY INFORMATION ABOUT MIRAPEX: MIRAPEX tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
MIRAPEX may cause you to fall asleep without any warning, even while doing normal daily activities, such as driving. When taking MIRAPEX, hallucinations may occur and sometimes you may feel dizzy, sweaty or nauseated upon standing up. The most common side effects in clinical trials for RLS were nausea, headache, and tiredness. You should talk with your doctor if you experience these problems.
Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease and RLS.
This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.
Please see full Prescribing Information, including patient information.
